Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Publication Date timeline is not available.
Page 1
Comparison of two biosimilarity studies of FKB327 with the adalimumab reference product: randomized phase 1 studies of single-blind, single-dose subcutaneous injection in healthy Japanese male participants.
BMC Pharmacol Toxicol. 2022 Jan 8;23(1):6. doi: 10.1186/s40360-021-00545-3.
BMC Pharmacol Toxicol. 2022.
PMID: 34998419
Free PMC article.
Clinical Trial.
Pharmacokinetics, safety, tolerability, and immunogenicity of FKB238, a new biosimilar of bevacizumab, in healthy participants.
Boyce M, Wilkes D, Kaito H, Takanuma M, Arai Y.
Boyce M, et al. Among authors: takanuma m.
Int J Clin Pharmacol Ther. 2022 Jun;60(6):280-290. doi: 10.5414/CP204211.
Int J Clin Pharmacol Ther. 2022.
PMID: 35361328
Clinical Trial.
Item in Clipboard
Efficacy and safety of benralizumab in Japanese patients with severe, uncontrolled eosinophilic asthma.
Ohta K, Adachi M, Tohda Y, Kamei T, Kato M, Mark Fitzgerald J, Takanuma M, Kakuno T, Imai N, Wu Y, Aurivillius M, Goldman M.
Ohta K, et al. Among authors: takanuma m.
Allergol Int. 2018 Apr;67(2):266-272. doi: 10.1016/j.alit.2017.10.004. Epub 2017 Nov 8.
Allergol Int. 2018.
PMID: 29128192
Free article.
Clinical Trial.
Item in Clipboard
Cite
Cite
ARTICLE TYPE
ARTICLE LANGUAGE
AGE
Filters on the sidebar will be reset to the default list and any currently applied filters will be cleared.